Target Health is pleased to announce that this past Friday it submitted an original IND, Original IDE and an IND supplement to FDA. One of our clients also received Orphan Drug Designation and there were three pre-approval inspections for a pending NDA. FDA may also be auditing us again. We also released Target Document® (TD) also for commercial use. TD is our web-based document management and document sharing system. Very special prices for any of our readers. Our goal is to have high volume, high quality and low price.

Contact julesmitchel@targethealth.com for a demo and 1 month free look.

For more information, please contact Dr. Jules T. Mitchel or Joyce Hays. For new business opportunities, contact Dr. Jules T. Mitchel